1166 related articles for article (PubMed ID: 27275104)
1. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
[TBL] [Abstract][Full Text] [Related]
3. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
[TBL] [Abstract][Full Text] [Related]
4. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
Li X; Tao LP; Wang CH
World J Gastroenterol; 2014 Sep; 20(34):12322-9. PubMed ID: 25232268
[TBL] [Abstract][Full Text] [Related]
7. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
[TBL] [Abstract][Full Text] [Related]
8. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
9. [Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis].
Döbrönte Z; Toldy E; Márk L; Sarang K; Lakner L
Orv Hetil; 2012 Jun; 153(25):990-6. PubMed ID: 22714033
[TBL] [Abstract][Full Text] [Related]
10. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
[TBL] [Abstract][Full Text] [Related]
11. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
Rustagi T; Njei B
Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
[TBL] [Abstract][Full Text] [Related]
12. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin].
Montaño Loza A; García Correa J; González Ojeda A; Fuentes Orozco C; Dávalos Cobián C; Rodríguez Lomelí X
Rev Gastroenterol Mex; 2006; 71(3):262-8. PubMed ID: 17140047
[TBL] [Abstract][Full Text] [Related]
14. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.
Sotoudehmanesh R; Khatibian M; Kolahdoozan S; Ainechi S; Malboosbaf R; Nouraie M
Am J Gastroenterol; 2007 May; 102(5):978-83. PubMed ID: 17355281
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial.
Park SW; Chung MJ; Oh TG; Park JY; Bang S; Park SW; Song SY
Endoscopy; 2015 Jan; 47(1):33-9. PubMed ID: 25409167
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes].
Montaño Loza A; Rodríguez Lomelí X; García Correa JE; Dávalos Cobián C; Cervantes Guevara G; Medrano Muñoz F; Fuentes Orozco C; González Ojeda A
Rev Esp Enferm Dig; 2007 Jun; 99(6):330-6. PubMed ID: 17883296
[TBL] [Abstract][Full Text] [Related]
18. Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis.
Shi QQ; Ning XY; Zhan LL; Tang GD; Lv XP
World J Gastroenterol; 2014 Jun; 20(22):7040-8. PubMed ID: 24944500
[TBL] [Abstract][Full Text] [Related]
19. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis.
Tse F; Yuan Y; Bukhari M; Leontiadis GI; Moayyedi P; Barkun A
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010571. PubMed ID: 27182692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
